前立腺肥大症の疫学的予測（～2024）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 Catalyst 6
2.2 Related Reports 7
2.3 Upcoming Reports 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 9
3.3 Global Trends 9
3.3.1 US 9
3.3.2 5EU 10
3.3.3 Japan 10
3.4 Forecast Methodology 10
3.4.1 Sources Used 11
3.4.2 Sources Not Used 12
3.4.3 Forecast Assumptions and Methods – Diagnosed Prevalent Cases 13
3.5 Epidemiological Forecast for BPH (2014-2024) 14
3.5.1 Diagnosed Prevalent Cases of BPH 14
3.5.2 Age-Specific Diagnosed Prevalent Cases of BPH 16
3.5.3 Diagnosed Prevalent Cases of BPH by Severity Using IPSS Criteria 17
3.5.4 Age Standardized Diagnosed Prevalence of BPH (%) 18
3.6 Discussion 19
3.6.1 Epidemiological Forecast Insight 19
3.6.2 Limitations of the Analysis 20
3.6.3 Strengths of the Analysis 20
4 Appendix 21
4.1 Bibliography 21
4.2 About the Authors 23
4.2.1 Epidemiologists 23
4.2.2 Reviewers 24
4.2.3 Global Director of Therapy Analysis and Epidemiology 25
4.2.4 Global Head of Healthcare 25
4.3 About GlobalData 26
4.4 About EpiCast 26
4.5 Disclaimer 27